Status:
UNKNOWN
Trial of Levofloxacin as Prophylaxis After Allogeneic Stem Cell Transplantation (SCT)
Lead Sponsor:
Charite University, Berlin, Germany
Conditions:
Malignancy
Allogeneic Stem Cell Transplantation
Eligibility:
All Genders
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of this study is to evaluate the efficacy of levofloxacin to prevent bacterial infections in the postneutropenic period in patients who have undergone allogeneic stem cell transplantation ...
Eligibility Criteria
Inclusion
- Allogeneic SCT
- Postneutropenic period
- Written consent
Exclusion
- Fever
- Antibiotic therapy
- Neutropenia
- Refusal by the patient
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00215007
Last Update
November 30 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Charite, CBF
Berlin, State of Berlin, Germany, 12200